Prognostic Factors for Adrenocortical Carcinoma Outcomes.

作者: Claudia Scollo , Marco Russo , Maria Antonietta Trovato , Daniela Sambataro , Dario Giuffrida

DOI: 10.3389/FENDO.2016.00099

关键词:

摘要: Purpose: Adrenocortical cancer (ACC) is an aggressive tumor characterised by a high recurrence rate and poor response to treatment. This study analyses consecutive series of ACC patients evaluate the prognostic value various clinical pathological characteristics. Methods: We retrospectively evaluated 32 followed at our Medical Center from 1997 2015 age diagnosis, gender, functional status, stage type treatment with respect overall survival (OS) disease-free (DFS) as determined Kaplan–Meier curves. Results: was associated hormonal overproduction in 50% cases, isolated hyperandrogenism had better prognosis. Recurrence observed 12/26 (46.2%) no evidence disease after surgery. Tumor size (HR 1.32, 95% CI 1.12–1.64; p=0.007), ki-67 1.06, 1.02–1.11; p=0.009) advanced diagnosis (III–IV) 6.51, 1.65–24.68; p=0.006) were 26 R0 univariate analysis. Advanced independent risk factor for multivariate analysis 8.10, 1.55–41.35; p=0.01). Five-year 40.0%. Positive resection margins 10.61, 3.02–38.31; p=<0.001), 1.04, 1.01–1.07; p=0.01) 11.31, 1.45–87.76; p=0.02) all patients, but only positive predictor mortality 6.22, 1.44–26.05; Conclusions: has prognosis rate. completeness surgical excision are most relevant factors.

参考文章(28)
A. Stigliano, I. Chiodini, R. Giordano, A. Faggiano, L. Canu, S. Della Casa, P. Loli, M. Luconi, F. Mantero, M. Terzolo, Management of adrenocortical carcinoma: a consensus statement of the Italian Society of Endocrinology (SIE) Journal of Endocrinological Investigation. ,vol. 39, pp. 103- 121 ,(2016) , 10.1007/S40618-015-0349-9
Rossella Libé, Adrenocortical carcinoma (ACC): diagnosis, prognosis, and treatment. Frontiers in Cell and Developmental Biology. ,vol. 3, pp. 45- 45 ,(2015) , 10.3389/FCELL.2015.00045
Stanley Sidhu, Glover, Ip, Zhao, Soon, Robinson, Current management options for recurrent adrenocortical carcinoma OncoTargets and Therapy. ,vol. 6, pp. 635- 643 ,(2013) , 10.2147/OTT.S34956
Georgios Antonios Margonis, Yuhree Kim, Jason D Prescott, Thuy B Tran, Lauren M Postlewait, Shishir K Maithel, Tracy S Wang, Douglas B Evans, Ioannis Hatzaras, Rivfka Shenoy, John E Phay, Kara Keplinger, Ryan C Fields, Linda X Jin, Sharon M Weber, Ahmed Salem, Jason K Sicklick, Shady Gad, Adam C Yopp, John C Mansour, Quan-Yang Duh, Natalie Seiser, Carmen C Solorzano, Colleen M Kiernan, Konstantinos I Votanopoulos, Edward A Levine, George A Poultsides, Timothy M Pawlik, None, Adrenocortical Carcinoma: Impact of Surgical Margin Status on Long-Term Outcomes Annals of Surgical Oncology. ,vol. 23, pp. 134- 141 ,(2016) , 10.1245/S10434-015-4803-X
Ivan Casaburi, Paola Avena, Arianna De Luca, Adele Chimento, Rosa Sirianni, Rocco Malivindi, Vittoria Rago, Marco Fiorillo, Francesco Domanico, Carmela Campana, Anna Rita Cappello, Federica Sotgia, Michael P. Lisanti, Vincenzo Pezzi, Estrogen related receptor α (ERRα) a promising target for the therapy of adrenocortical carcinoma (ACC) Oncotarget. ,vol. 6, pp. 25135- 25148 ,(2015) , 10.18632/ONCOTARGET.4722
Martin Fassnacht, Matthias Kroiss, Bruno Allolio, Update in Adrenocortical Carcinoma The Journal of Clinical Endocrinology and Metabolism. ,vol. 98, pp. 4551- 4564 ,(2013) , 10.1210/JC.2013-3020
M. Terzolo, B. Allolio, R. Chadarevian, H. H. Mueller, B. Skogseid, S. Leboulleux, F. Mantero, H. R. Haak, M. Fassnacht, T. M. Kerkhofs, E. Baudin, Comparison of Two Mitotane Starting Dose Regimens in Patients With Advanced Adrenocortical Carcinoma The Journal of Clinical Endocrinology & Metabolism. ,vol. 98, pp. 4759- 4767 ,(2013) , 10.1210/JC.2013-2281
Daniel Soares Freire, Sheila Aparecida Coelho Siqueira, Maria Cláudia Nogueira Zerbini, Bernardo Léo Wajchenberg, Maria Lúcia Corrêa-Giannella, Antônio Marmo Lucon, Maria Adelaide Albergaria Pereira, Development and internal validation of an adrenal cortical carcinoma prognostic score for predicting the risk of metastasis and local recurrence. Clinical Endocrinology. ,vol. 79, pp. 468- 475 ,(2013) , 10.1111/CEN.12174
Anthony Stell, Martin Reincke, Mauro Papotti, Eric Baudin, Frédérique Tissier, Harm R. Haak, Paola Loli, Massimo Terzolo, Bruno Allolio, Hans-Helge Müller, Martin Fassnacht, Felix Beuschlein, Jens Weigel, Wolfgang Saeger, Matthias Kroiss, Vanessa Wild, Fulvia Daffara, Rosella Libé, Arianna Ardito, Abir Al Ghuzlan, Marcus Quinkler, Andrea Oßwald, Cristina L. Ronchi, Ronald de Krijger, Richard A. Feelders, Jens Waldmann, Holger S. Willenberg, Timo Deutschbein, Major Prognostic Role of Ki67 in Localized Adrenocortical Carcinoma After Complete Resection The Journal of Clinical Endocrinology and Metabolism. ,vol. 100, pp. 841- 849 ,(2015) , 10.1210/JC.2014-3182
Philippe Icard, Pierre Goudet, Cyril Charpenay, Bernard Andreassian, Bruno Carnaille, Yves Chapuis, Patrick Cougard, Jean-François Henry, Charles Proye, Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group. World Journal of Surgery. ,vol. 25, pp. 891- 897 ,(2001) , 10.1007/S00268-001-0047-Y